DUBLIN, March 13, 2020 /PRNewswire/ -- The "Venous Thromboembolism Global Clinical Trials Review, H1, 2020" report has been added to ResearchAndMarkets.com's offering.
Venous Thromboembolism Global Clinical Trials Review, H1, 2020 provides an overview of Venous Thromboembolism Clinical trials scenario.
This report provides top line data relating to the clinical trials on Venous Thromboembolism. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).
- The report provides a snapshot of the global clinical trials landscape
- It povides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- Reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- Provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The study provides enrollment trends for the past five years
- The report provides latest news for the past three months
Key Topics Covered
- Report Guidance
- Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials
- Prominent Drugs
- Clinical Trial Profile Snapshots
- C. H. Boehringer Sohn AG & Co. KG
- Bayer AG
- Bristol-Myers Squibb Co.
- Johnson & Johnson
- Daiichi Sankyo Co. Ltd.
- Pfizer Inc.
- GlaxoSmithKline PLC
- Portola Pharmaceuticals Inc.
- Astellas Pharma Inc.
For more information about this report visit https://www.researchandmarkets.com/r/n734gu
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/venous-thromboembolism-clinical-trials-insights-h1-2020-by-trial-status-trial-phase-sponsor-type-end-point-status-region-and-country-301022925.html
SOURCE Research and Markets